F&P's share price rises on news of court battle success
One patent dispute won – but two to go.
Fisher & Paykel Healthcare [NZX:FPH] has managed to fend off accusations of copycatting from its rival – for now.
The Auckland-based medical device maker announced this morning the District Court in Munich has overturned both preliminary injunctions previously granted to ResMed [NYSE:RMD]
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Fri, 02 Dec 2016
Fri, 02 Dec 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
F&P's share price rises on news of court battle success
63576